Milnacipran inhibits oxaliplatin-induced mechanical allodynia through spinal action in mice

Biological and Pharmaceutical Bulletin

Volumn 38, Issue 1, 2015, Pages 151-154

  Andoh, Tsugunobu ^a   Kitamura, Ryo ^a   Kuraishi, Yasushi ^a  

^a TOYAMA PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Allodynia; Intrathecal injection; Milnacipran; Oxaliplatin; Spinal cord

Indexed keywords

MILNACIPRAN; OXALIPLATIN; ANTINEOPLASTIC AGENT; CYCLOPROPANE DERIVATIVE; PLATINUM COMPLEX; SEROTONIN UPTAKE INHIBITOR;

ALLODYNIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; EXPERIMENTAL BEHAVIORAL TEST; MALE; MOUSE; NONHUMAN; OXALIPLATIN INDUCED MECHANICAL ALLODYNIA; SINGLE DRUG DOSE; SPINAL CORD; VON FREY TEST; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DRUG ADMINISTRATION ROUTE; DRUG EFFECTS; HYPERALGESIA;

ANIMALS; ANTINEOPLASTIC AGENTS; CYCLOPROPANES; DRUG ADMINISTRATION ROUTES; HYPERALGESIA; MALE; MICE, INBRED C57BL; ORGANOPLATINUM COMPOUNDS; SEROTONIN UPTAKE INHIBITORS; SPINAL CORD;

EID: 84920517167     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00581     Document Type: Article

References (26)

1. Park SB, Goldstein D, Krishnan AV, Lin CS, Friedlander ML, Cassidy J, Koltzenburg M, Kiernan MC. Chemotherapy-induced peripheral neurotoxicity: A critical analysis. CA Cancer J. Clin., 63, 419-437 (2013).
2. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J. Neurol., 249, 9-17 (2002).
3. Sakurai M, Egashira N, Kawashiri T, Yano T, Ikesue H, Oishi R. Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia. Pain, 147, 165-174 (2009).
4. Pasetto LM, D'Andrea MR, Rossi E, Monfardini S. Oxaliplatinrelated neurotoxicity: how and why? Crit. Rev. Oncol. Hematol., 59, 159-168 (2006).
5. Saif MW, Reardon J. Management of oxaliplatin-induced peripheral neuropathy. Ther. Clin. Risk Manag., 1, 249-258 (2005).
6. Kitamura R, Andoh T, Fushimi H, Komatsu K, Shibahara N, Kuraishi Y. Involvement of descending monoaminergic systems in antiallodynic effect of goshajinkigan in oxaliplatin-treated mice. J. Trad. Med., 30, 183-189 (2013).
7. Vaishnavi SN, Nemeroff CB, Plott SJ, Rao SG, Kranzler J, Owens MJ. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Biol. Psychiatry, 55, 320-322 (2004).
8. Kautio AL, Haanpaa M, Leminen A, Kalso E, Kautiainen H, Saarto T. Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms. Anticancer Res., 29, 2601-2606 (2009).
9. Durand JP, Deplanque G, Montheil V, Gornet JM, Scotte F, Mir O, Cessot A, Coriat R, Raymond E, Mitry E, Herait P, Yataghene Y, Goldwasser F. Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Ann. Oncol., 23, 200-205 (2012).
10. Yang YH, Lin JK, Chen WS, Lin TC, Yang SH, Jiang JK, Chang SC, Lan YT, Lin CC, Yen CC, Tzeng CH, Wang WS, Chiang HL, Teng CJ, Teng HW. Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study. Support. Care Cancer, 20, 1491-1497 (2012).
11. King T, Rao S, Vanderah T, Chen Q, Vardanyan A, Porreca F. Differential blockade of nerve injury-induced shift in weight bearing and thermal and tactile hypersensitivity by milnacipran. J. Pain, 7, 513-520 (2006).
12. Suzuki T, Ueta K, Tamagaki S, Mashimo T. Antiallodynic and antihyperalgesic effect of milnacipran in mice with spinal nerve ligation. Anesth. Analg., 106, 1309-1315 (2008).
13. Katsuyama S, Sato K, Yagi T, Kishikawa Y, Nakamura H. Effects of repeated milnacipran and fluvoxamine treatment on mechanical allodynia in a mouse paclitaxel-induced neuropathic pain model. Biomed. Res., 34, 105-111 (2013).
14. Gauchan P, Andoh T, Kato A, Sasaki A, Kuraishi Y. Effects of the prostaglandin E1 analog limaprost on mechanical allodynia caused by chemotherapeutic agents in mice. J. Pharmacol. Sci., 109, 469-472 (2009).
15. Takasaki I, Andoh T, Nojima H, Shiraki K, Kuraishi Y. Gabapentin antinociception in mice with acute herpetic pain induced by herpes simplex virus infection. J. Pharmacol. Exp. Ther., 296, 270-275 (2001).
16. Obata H, Kimura M, Nakajima K, Tobe M, Nishikawa K, Saito S. Monoamine-dependent, opioid-independent antihypersensitivity effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a postoperative pain model in rats. J. Pharmacol. Exp. Ther., 334, 1059-1065 (2010).
17. Moret C, Charveron M, Finberg JP, Couzinier JP, Briley M. Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug. Neuropharmacology, 24, 1211-1219 (1985).
18. Millan MJ. Descending control of pain. Prog. Neurobiol., 66, 355-474 (2002).
19. Yoshimura M, Furue H. Mechanisms for the anti-nociceptive actions of the descending noradrenergic and serotonergic systems in the spinal cord. J. Pharmacol. Sci., 101, 107-117 (2006).
20. Tibiriça E, Feldman J, Mermet C, Gonon F, Bousquet P. An imidazolinespecific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan. J. Pharmacol. Exp. Ther., 256, 606-613 (1991).
21. Berrocoso E, Mico JA. In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, a2-adrenergic, and 5-hydroxytryptamine1A receptors. J. Pharmacol. Exp. Ther., 322, 101-107 (2007).
22. Alba-Delgado C, Mico JA, Sanchez-Blazquez P, Berrocoso E. Analgesic antidepressants promote the responsiveness of locus coeruleus neurons to noxious stimulation: implications for neuropathic pain. Pain, 153, 1438-1449 (2012).
23. Bruzos-Cidón C, Miguelez C, Rodriguez JJ, Gutierrez-Lanza R, Ugedo L, Torrecilla M. Altered neuronal activity and differential sensitivity to acute antidepressants of locus coeruleus and dorsal raphe nucleus in Wistar Kyoto rats: A comparative study with Sprague Dawley and Wistar rats. Eur. Neuropsychopharmacol., 24, 1112-1122 (2014).
24. Mateo Y, Ruiz-Ortega JA, Pineda J, Ugedo L, Meana JJ. Inhibition of 5-hydroxytryptamine reuptake by the antidepressant citalopram in the locus coeruleus modulates the rat brain noradrenergic transmission in vivo. Neuropharmacology, 39, 2036-2043 (2000).
25. Zhao M, Nakamura S, Miyake T, So K, Shirakawa H, Tokuyama S, Narita M, Nakagawa T, Kaneko S. Pharmacological characterization of standard analgesics on oxaliplatin-induced acute cold hypersensitivity in mice. J. Pharmacol. Sci., 124, 514-517 (2014).
26. Sada H, Egashira N, Ushio S, Kawashiri T, Shirahama M, Oishi R. Repeated administration of amitriptyline reduces oxaliplatininduced mechanical allodynia in rats. J. Pharmacol. Sci., 118, 547-551 (2012).